Insider Monkey44d agoneutral
Eli Lilly (LLY) vs. Novo Nordisk (NVO): Has the GLP-1 Race Changed the Moat?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3128last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Stocktwits44d agoneutral
Biotech Deal Week: Lilly, Novo And Novartis Pay Up For Platforms, Not PipelinesMotley Fool44d agoneutral
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product?MT Newswires44d agoneutral
European Markets Close Mostly Higher Friday on Hopes for US-Iran Strait DealMotley Fool44d agobullish
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?The Wall Street Journal44d agoneutral
Novo Nordisk to Pay Up to $1.3 Billion for Nanexa’s Drug Delivery TechnologyMotley Fool45d agobullish
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?Simply Wall St.45d agoneutral
Novo Nordisk (NVO) Sets Pipeline Sales Target Above $23 Billion By 2035MT Newswires45d agoneutral
European Equities Traded in the US as American Depositary Receipts Edge Lower in Thursday TradingClinical Trials Arena46d agoneutral
European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance